Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dravet Syndrome Indication Will Set GW Pharma Apart On US Epilepsy Market
Sep 27 2016
•
By
Lucie Ellis-Taitt
Epidiolex's potential in Dravet syndrome will be its competitive edge • Source: Shutterstock/Tashatuvango
More from Neurological
More from Therapy Areas